This company seems to have been delisted
Reason: Delisted by Nasdaq
Last recorded trade on: February 22, 2023
Source: https://www.globenewswire.com/en/news-release/2022/12/28/2580400/6948/en/Delisting-of-Securities-of-Tuscan-Holdings-Corp-II-Clovis-Oncology-Inc-ZyVersa-Therapeutics-Inc-Otonomy-Inc-and-Forward-Pharma-A-S-from-The-Nasdaq-Stock-Market.html
Reason: Delisted by Nasdaq
Last recorded trade on: February 22, 2023
Source: https://www.globenewswire.com/en/news-release/2022/12/28/2580400/6948/en/Delisting-of-Securities-of-Tuscan-Holdings-Corp-II-Clovis-Oncology-Inc-ZyVersa-Therapeutics-Inc-Otonomy-Inc-and-Forward-Pharma-A-S-from-The-Nasdaq-Stock-Market.html
Clovis Oncology
CLVS
£0.06269
Share price
0.00%
Change (1 day)
-95.20%
Change (1 year)
Categories
Clovis Oncology (CLVS) - Total debt
Total debt on the balance sheet as of September 2022 : £0.52 Billion
According to Clovis Oncology's latest financial reports the company's total debt is £0.52 Billion. A company’s total debt is the sum of all current and non-current debts.
Clovis Oncology - Total debt on balance sheet (from 2011 to 2022)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2021-12-31 | £0.47 B | -0.36% |
| 2020-12-31 | £0.47 B | -12.91% |
| 2019-12-31 | £0.54 B | 19.99% |
| 2018-12-31 | £0.45 B | 117.35% |
| 2017-12-31 | £0.20 B | -8.29% |
| 2016-12-31 | £0.22 B | 20.63% |
| 2015-12-31 | £0.18 B | 2.28% |
| 2014-12-31 | £0.18 B |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 | £0.46 B | -11.45% | 🇺🇸 USA |
 | £23.25 B | 4,324.50% | 🇬🇧 UK |
 | £49.14 B | 9,251.62% | 🇺🇸 USA |
 | £28.28 B | 5,282.45% | 🇺🇸 USA |
 | £51.84 B | 9,765.12% | 🇺🇸 USA |
 | £25.97 B | 4,843.17% | 🇺🇸 USA |